Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders

Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders

Abstract Gene therapy using recombinant adeno‐associated virus (rAAV) vectors to treat blinding retinal dystrophies has become clinical reality. Therapeutically impactful targeting of photoreceptors still relies on subretinal vector delivery, which detaches the retina and harbours substantial risks...

Full description

Bibliographic Details
Main Authors: Marina Pavlou, Christian Schön, Laurence M Occelli, Axel Rossi, Nadja Meumann, Ryan F Boyd, Joshua T Bartoe, Jakob Siedlecki, Maximilian J Gerhardt, Sabrina Babutzka, Jacqueline Bogedein, Johanna E Wagner, Siegfried G Priglinger, Martin Biel, Simon M Petersen‐Jones, Hildegard Büning, Stylianos Michalakis
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:EMBO Molecular Medicine
Subjects:
achromatopsia
intravitreal delivery
novel AAV
retina
Online Access:https://doi.org/10.15252/emmm.202013392

Internet

https://doi.org/10.15252/emmm.202013392

Similar Items